Improving coronavirus testing with engineered RNA elements
Model-guided design of RNA stabilizing elements for improved coronavirus diagnostics
This study is working on creating quicker and more affordable ways to test for the COVID-19 virus, making it easier for everyone to get accurate results without needing complicated equipment or special training.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-10280880 on NIH RePORTER |
What this research studies
This research focuses on developing faster, cheaper, and more sensitive methods for detecting the SARS-CoV-2 coronavirus, which causes COVID-19. It aims to overcome the limitations of current testing methods, such as RT-PCR, which require specialized equipment and trained personnel. By engineering RNA molecules to resist degradation, the project seeks to enhance the stability and performance of diagnostic tests, making them easier to deploy in various settings. The approach includes using innovative RNA technologies like toehold switches and CRISPR/Cas systems to improve the sensitivity and specificity of tests.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who require COVID-19 testing, particularly in settings where rapid and accurate diagnostics are crucial.
Not a fit: Patients who are not affected by COVID-19 or do not require testing for the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and reliable coronavirus testing, helping to control the spread of COVID-19.
How similar studies have performed: Other research has shown promise in using engineered RNA technologies for diagnostics, indicating that this approach has potential for success.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Wang, Xiao — Arizona State University-Tempe Campus
- Study coordinator: Wang, Xiao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.